Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
13,207,308
-
Share change
-
-1,093,025
-
Total reported value
-
$30,239,000
-
Price per share
-
$2.29
-
Number of holders
-
35
-
Value change
-
-$4,288,060
-
Number of buys
-
7
-
Number of sells
-
21
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2018
As of 31 Dec 2018,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,207,308 shares.
The largest 10 holders included
STONEHILL CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, JANUS HENDERSON GROUP PLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, 22NW, LP, HEARTLAND ADVISORS INC, Russell Investments Group, Ltd., Lapides Asset Management, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.